Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Explore this paper's citation graph
Summary
Using immunohistochemistry, it is found that Glut1 is largely undetectable in normal epithelial tissues and benign epithelial tumors but is expressed in a significant proportion of a variety of human carcinomas.
- Type
- article
- Published
- 1996-03-01
- Cited by
- 380
- References
- 0
- OpenAlex
- https://openalex.org/W1800961333
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36711514
Keywords
GLUT1, Glucose transporter, Immunohistochemistry, Glucose Transporter Type 1, Glucose uptake
References
No references recorded for this paper.
Cited by
- The utility of GLUT‐1 immunolocalization in cell blocks
- Clinical impact of the Warburg effect in gastrointestinal cancer (review).
- Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
- Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
- Mitochondria and apoptosis: new therapeutic targets.
- A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
- Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux
- Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.
- Sauerstoffverbrauchsmessungen an humanen Neuroblastomzellen und an isolierten Mitochondrien
- HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas.
- Endogenous Markers of Tumor Hypoxia
- Caracterització i regulació transcripcional del gen "pfkfb3"
- The Role of the Transcription Factor Ets-1 in Mitochondrial Metabolism and Oxidative Stress
- Role of stromal fibroblasts in prostate carcinoma progression and metabolic reprogramming of cancer cells
- Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
- GLUT1 glucose transporter expression in colorectal carcinoma
- Recent developments in benign peripheral nerve sheath tumors
- Loss of GLUT4 Induces Metabolic Reprogramming and Impairs Viability of Breast Cancer Cells
- Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
- Dictyostelium differentiation‐inducing factor‐1 induces glucose transporter 1 translocation and promotes glucose uptake in mammalian cells
Related papers
- Insulin therapy normalizes GLUT1 glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats.
- Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes.
- Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity.
- Myocardial gene expression of glucose transporter 1 and glucose transporter 4 in response to uteroplacental insufficiency in the rat.
- Glucose Transporter-1 in the Hypothalamic Glial Cells Mediates Glucose Sensing to Regulate Glucose Production In Vivo
- Normal muscle glucose uptake in mice deficient in muscle GLUT4.
- Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.
- Modulation of the activity of glucose transporters (GLUT) in the aged/obese rat adipocyte: suppressed function, but enhanced intrinsic activity of GLUT.
- Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM